Key result
Remote monitoring of ICMs achieves ~98% transmission success over 13 months.
Why the study?
The study appraised whether physicians can rely on implantable cardiac monitor remote monitoring to be informed of all possibly significant arrhythmias.
Does remote monitoring of implantable cardiac monitors reliably transmit significant arrhythmias in patients with ICMs?
Observational (n=212)
Does remote monitoring of implantable cardiac monitors reliably transmit significant arrhythmias in patients with ICMs?
Remote monitoring of implantable cardiac monitors has a high transmission success rate (98%), but transmitting only one episode per day may lead to the loss of clinically relevant information.
Physicians cannot rely on daily ICM remote monitoring for all significant arrhythmias; leaves open completeness of automated ECG transmissions in ongoing trials.
INTRODUCTION: Remote monitoring including transmission of electrocardiogram (ECG) strips has been implemented in implantable cardiac monitors (ICM). We appraise whether the physician can rely on remote monitoring to be informed of all possibly significant arrhythmias. METHODS: We analyzed remote monitoring transmissions of patients in the ongoing BIO|GUARD-MI study, in which Biotronik devices are used. Once per day, the devices automatically transmit messages with up to six ECG snapshots to the Home Monitoring Service Center. If more than one type of arrhythmia is recorded during a day, at least one ECG of each arrhythmia type is transmitted. RESULTS: 212 study patients were registered at the service center. The mean age of the patients was 70 ± 8 years, and 74% were male. Patients were followed for an average of 13 months. The median time from device implantation until the first message receipt in the service center was 2 days. The median patient-individual transmission success was 98.0% (IQR 93.6-99.8) and remained stable in the second and third year. The most frequent arrhythmias were atrial fibrillation, bradycardia and high ventricular rate. 17.3% of the messages with ECG snapshots contained more than one arrhythmia type. DISCUSSION: Our analysis confirms that the physician can rely on Home Monitoring to be informed of all possibly significant arrhythmias during long-term follow-up. We have found hints that the transmission of only one episode per day may lead to the loss of clinically relevant information if patients with ICMs are followed by remote monitoring only.
No takes yet. Share an insight, caveat, or question.
Søgaard et al. (2019) conducted an observational in Implantable cardiac monitors (n=212). Remote monitoring via implantable cardiac monitors was evaluated on Patient-individual transmission success. Remote monitoring of implantable cardiac monitors achieved a median patient-individual transmission success of 98.0% over an average 13-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: